Abstract

In this paper, we try to focus on analyzing the prescription cost. Pharmaceutical costs are the major item of expenditure in the areas of care primary. The need to contain health spending has led to the search for alternatives in this field, one of which would promote a policy prescription that used the cheapest presentation for each active ingredient. The objective of this work is to evaluate the amount that would be saved if they chose to prescribe the cheaper alternative in a choice of anti-infective drugs. The paper also gives the major difference between the Generic vs. Brand name and does generic name or brand has any impact on prices. The paper includes the difference between insurance holder and no insurance holder and does; it has any impact on prices. Paper also provides some tips on how to save money on prescription drug costs. Paper finally, concludes with the overall discussion. Financially if the pharmaceutical sector is the most important part of our practice, it is also the one who accuses recent years the fastest growing. As part of the evaluation of the sum in practice primary care, it was therefore particularly important to analyze the costs of prescription drugs.

Analyzing prescription cost

Thesis Statement

Prices are high because, individual spending has been increasing.

Introduction

The pharmaceutical spending represents approximately 20% of the budget total for the health care system 1.2 National Health. 90% of the consumption of drugs corresponding to prescriptions made ??by primary care physicians, where for the management of this level of cares the largest item of expenditure. Its growth in recent years is mainly due to increase in price per prescription and the increased number of prescriptions to pensioners, as the number of prescriptions has remained relatively stable. The emergence of new molecules in the market (with a high price) and the promotion of industry to the prescribing pharmaceutical it has been suggested, also, as factors linked to increase spending.

In these circumstances, we have generated numerous studies 3-10 on the determinants of the prescription, especially after the implementation of policy for the Rational Use of Medicines (URM), whose objectives are focused on cost containment while maintaining quality on prescription. One option raised is lowering the price per prescription by prescription brand recorded cheapest on the market, without detriment to the therapeutic qualities. This study has analyzed the proposal for a group of certain drugs, anti-infective. Bacterial infectious disease is a common ...